The macrophage is a key cell in the pro-and anti-inflammatory response including that of the
inflammatory microenvironment of malignant tumors. Much current drug development in …

Doxorubicin (DOX) is a highly effective chemotherapy agent that often causes cardiotoxicity.
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …

Intramyocardial hemorrhage (IMH), a reperfusion therapy-associated complication, is the
extravasation of red blood cells caused by severe microvascular injury. IMH is an …

Patients with heart failure (HF) and coronary artery disease (CAD) have a high risk for
cardiovascular (CV) events including HF hospitalization, stroke, myocardial infarction (MI) …

Heart failure (HF) is the end stage of most cardiovascular diseases and remains a significant
health problem globally. We aimed to assess whether patients with left ventricular ejection …

The aim of our observational study was to derive a small set out of 92 repeatedly measured
biomarkers with optimal predictive capacity for adverse clinical events in heart failure, which …

Introduction Heart failure (HF) secondary to acute myocardial infarction (AMI) is still a
worldwide problem with a high mortality rate. The current study aimed to explore early and …

Coronary artery disease (CAD) and associated comorbidities such as heart failure (HF)
remain the leading cause of morbidity and mortality worldwide attributed to, at least partially …

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, and the incidence of new-
onset AF has been increasing over the past two decades. Several factors contribute to the …

Aims This study aims to provide insight into sex‐specific cardiovascular protein profiles and
their associations with adverse outcomes, which may contribute to a better understanding of …